Decibel Therapeutics, Inc.
SEC CIK 1656536 · [DBTX] · last insider filing 2023-09-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mclaughlin Kevin F | Director | filed 2022 - 2023 |
| Reid Laurence | Director · See Remarks | filed 2021 - 2023 |
| Kapusta Matthew C | Director | filed 2023 - 2023 |
| Finger Alison Cecily | Director | filed 2021 - 2023 |
| Carson William H. | Director | filed 2021 - 2023 |
| Nochur Sara | Director | filed 2021 - 2023 |
| Thompson Peter A. | Director | filed 2021 - 2022 |
| Exter Neil | Director | filed 2021 - 2022 |
| Orbimed Advisors LLC | Director | filed 2021 - 2021 |
| GSK plc | Director | filed 2021 - 2021 |
| Orbimed Capital LLC | Director | filed 2021 - 2021 |
| Orbimed Genesis GP LLC | Director | filed 2021 - 2021 |
| Foy Matthew | Director | filed 2021 - 2021 |
| Orbimed Capital GP Viii LLC | Director | filed 2021 - 2021 |
| Poon Christine A | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Trask Anna | See Remarks | filed 2021 - 2023 |
| Lee John Jui-Jen | See Remarks | filed 2021 - 2023 |
| Murphy James B | See Remarks | filed 2022 - 2022 |
| Leiderman Elisabeth | See Remarks | filed 2021 - 2022 |
| Wong Cynthia | General Counsel | filed 2021 - 2021 |
| See Remarks | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.